2m 2m 2m 2m 2m 2m 2m
ABSCI (ABSI)
NASDAQ
$8.08+$0.30 (+3.91%)
Price as of Aug 03, 2026 7:15 AM EDT- $1.3BMarket Cap
- 168.28%1-Year Change
- BiotechnologyIndustry
ABSCI (ABSI)
$8.08+$0.30 (+3.91%)
ABSI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $7.78 | ||
Change | +$0.14 (+1.83%) | ||
Open | $7.81 | ||
High | $8.14 | ||
Low | $7.44 | ||
Previous Close | $7.64 | ||
Volume | 2,085,634 | ||
30-Day Average Volume | 3,850,178 | ||
1-Week Change | 2.91% | ||
1-Month Change | -32.87% | ||
1-Year Change | 168.28% | ||
3-Year Change | 253.64% | ||
5-Year Change | -72.68% | ||
Fundamentals | |||
Shares Outstanding | 169.4M | ||
Total Assets | $195.6M | ||
Market Cap | $1.3B | ||
Enterprise Value | $1.3B | ||
Period: QTR TTM FY | |||
Revenue | $215,000.00 | ||
Net Income | -$29.6M | ||
Free Cash Flow | -$26.3M | ||
EBIT | -$29.6M | ||
EBITDA | -$26.9M | ||
Net Working Capital | $111.9M | ||
EPS | -$0.19 | ||
Enterprise Value/EBITDA | -49 | ||
Enterprise Value/Revenue | 6,092 | ||
P/B | 8 | ||
P/E | -41 | ||
PEG | -14 | ||
Price/Free Cash Flow | -50 | ||
Price/Operating Cash Flow | -50 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue